DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 089572
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
NDA 089572 describes PYRIDOSTIGMINE BROMIDE, which is a drug marketed by Novitium Pharma, Alvogen, Impax Labs Inc, Rising, Ani Pharms Inc, Elysium, Impax Labs, Solvay, Us Army, and Zydus Pharms, and is included in eleven NDAs. It is available from twelve suppliers. Additional details are available on the PYRIDOSTIGMINE BROMIDE profile page.
The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
Summary for 089572
| Tradename: | PYRIDOSTIGMINE BROMIDE |
| Applicant: | Solvay |
| Ingredient: | pyridostigmine bromide |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 089572
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 30MG | ||||
| Approval Date: | Nov 27, 1990 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
